Loos
France
77
2024-07-18
71
2025-02-25
These are the the leading inventors for applications assigned to GENFIT:
GENFIT based in Loos, FR has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
NITAZOXANIDE IN THE TREATMENT OF SEPSIS
#2 | 2024-05-16 ✅ Patent 12,233,038 granted on 2025-02-25Methods of treatment of cholestatic diseases
#3 | 2024-03-21 ✅ Patent 12,295,928 granted on 2025-05-13Methods of treatment of cholestatic diseases
#4 | 2024-03-14 ✅ Patent 12,290,498 granted on 2025-05-06Methods of treatment of cholestatic diseases
#5 | 2024-03-14 ✅ Patent 12,310,935 granted on 2025-05-27Methods of treatment of cholestatic diseases
#6 | 2024-03-07 ✅ Patent 12,303,480 granted on 2025-05-20Methods of treatment of cholestatic diseases
#7 | 2024-03-07 ✅ Patent 12,295,927 granted on 2025-05-13Methods of treatment of cholestatic diseases
#8 | 2023-10-26 ✅ Patent 11,857,523 granted on 2024-01-02Methods of treatment of cholestatic diseases
#9 | 2023-10-19 ✅ Patent 11,850,223 granted on 2023-12-26Methods of treatment of cholestatic diseases
#10 | 2023-09-28 ✅ Patent 12,589,086 granted on 2026-03-31COMPOSITIONS AND METHODS FOR THE TREATMENT OF PRIMARY BILIARY CHOLANGITIS
#11 | 2023-09-21 ✅ Patent 12,638,460 granted on 2026-05-26METHOD FOR NASH RISK ASSESSMENT
#12 | 2023-03-30 ✅ Patent 12,522,564 granted on 2026-01-13POLYMORPHS OF ELAFIBRANOR
#13 | 2023-02-09 ✅ Patent 12,391,712 granted on 2025-08-19PHOSPHATE DERIVATIVES OF RORGAMMA MODULATORS AND USES THEREOF
#14 | 2022-12-29METHODS FOR DIAGNOSING AND EVALUATING NON-ALCOHOLIC STEATOHEPATITIS
#15 | 2022-11-17 ✅ Patent 12,458,612 granted on 2025-11-04COMBINATION THERAPY COMPRISING COMPOUNDS OF FORMULA (I) AND GLP-1 RECEPTOR AGONISTS
#16 | 2022-06-09 ✅ Patent 12,208,087 granted on 2025-01-28Combination of nitazoxanide and elafibranor for the treatment of immune diseases or inflammation
#17 | 2022-05-05 ✅ Patent 11,974,997 granted on 2024-05-07RORgamma modulators and uses thereof
#18 | 2022-05-05 ✅ Patent 12,053,445 granted on 2024-08-06Methods of treatment of cholestatic diseases
#19 | 2021-10-07 ✅ Patent 12,030,840 granted on 2024-07-09Elafibranor salts
#20 | 2021-09-09 ✅ Patent 12,053,456 granted on 2024-08-06Pharmaceutical compositions for combination therapy
#21 | 2021-06-24 ✅ Patent 11,676,269 granted on 2023-06-13Automated pattern recognition and scoring method of histological images
#22 | 2020-10-29 ✅ Patent 11,400,078 granted on 2022-08-02Methods of treatment for cholestatic and fibrotic diseases
#23 | 2020-10-08 ✅ Patent 11,103,484 granted on 2021-08-31Methods of treatment for cholestatic and fibrotic diseases
#24 | 2020-09-24 ✅ Patent 11,331,292 granted on 2022-05-17Methods of treatment of cholestatic diseases
#25 | 2020-07-09 ✅ Patent 11,519,034 granted on 2022-12-06Non-invasive diagnostic of non-alcoholic fatty liver diseases, non-alcoholic steatohepatitis and/or liver fibrosis
#26 | 2020-07-02 ✅ Patent 11,484,517 granted on 2022-11-01Combination comprising a PPAR agonist such as elafibranor and an acetyl-CoA carboxylase (ACC) inhibitor
#27 | 2020-04-23 ✅ Patent 11,478,440 granted on 2022-10-25Combination of Elafibranor or derivatives thereof with an anti-NASH, anti-fibrotic or anti-cholestatic agent
#28 | 2020-02-27 ✅ Patent 11,191,749 granted on 2021-12-07Pharmaceutical compositions for combination therapy
#29 | 2020-01-02 ✅ Patent 11,077,115 granted on 2021-08-03Rorgamma modulators and uses thereof
#30 | 2019-12-26 ✅ Patent 11,160,801 granted on 2021-11-02RORgamma modulators and uses thereof
#31 | 2019-12-26 ✅ Patent 11,033,534 granted on 2021-06-15Pharmaceutical compositions for combination therapy
#32 | 2019-12-26 ✅ Patent 11,590,108 granted on 2023-02-28Pharmaceutical compositions for combination therapy
#33 | 2019-12-05 ✅ Patent 11,052,092 granted on 2021-07-06N-{[2-(piperidin-1-yl)phenyl](phenyl)methyl}-2-(3-oxo-3,4-dihydro-2H-1,4-benzoxazin-7-yl)acetamide derivatives and related compounds as ROR-gamma modulators for treating autoimmune diseases
#34 | 2019-11-28 ✅ Patent 10,987,351 granted on 2021-04-27RORgamma modulators and uses thereof
#35 | 2019-11-21 ✅ Patent 12,104,209 granted on 2024-10-01Non-invasive diagnostic of non-alcoholic steatohepatitis
#36 | 2019-09-12 ✅ Patent 10,722,575 granted on 2020-07-28Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disorders
#37 | 2019-04-18 ✅ Patent 11,185,519 granted on 2021-11-30Methods of treatment of cholestatic diseases
#38 | 2019-03-21 ✅ Patent 10,905,680 granted on 2021-02-02Methods of treatment for cholestatic and fibrotic diseases
#39 | 2018-10-04 ✅ Patent 10,653,678 granted on 2020-05-19Methods of treatment for cholestatic and fibrotic diseases
#40 | 2018-10-04 ✅ Patent 10,350,181 granted on 2019-07-16Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disorders
#41 | 2018-09-20 ✅ Patent 11,371,098 granted on 2022-06-28Methods for diagnosing and evaluating non-alcoholic steatohepatitis
#42 | 2018-04-05 ✅ Patent 10,130,613 granted on 2018-11-20Methods of treatment for cholestatic and fibrotic diseases
#43 | 2018-04-05 ✅ Patent 10,117,856 granted on 2018-11-06Methods of treatment for cholestatic and fibrotic diseases
#44 | 2018-04-05 ✅ Patent 10,117,855 granted on 2018-11-06Methods of treatment for cholestatic and fibrotic diseases
#45 | 2018-03-29 ✅ Patent 10,130,612 granted on 2018-11-20Methods of treatment for cholestatic and fibrotic diseases
#46 | 2017-12-28 ✅ Patent 10,022,343 granted on 2018-07-17Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disorders
#47 | 2017-12-07 ✅ Patent 9,902,725 granted on 2018-02-27Heterocyclic derivatives as RORgamma modulators
#48 | 2017-10-19 ✅ Patent 10,799,510 granted on 2020-10-13Derivatives of 6-substituted triazolopyridazines as Rev-Erb agonists
#49 | 2017-08-24 ✅ Patent 10,792,277 granted on 2020-10-06Methods of treatment of fibrosis and cancers
#50 | 2017-05-11 ✅ Patent 9,782,373 granted on 2017-10-10Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disorders
#51 | 2016-02-25 ✅ Patent 9,585,853 granted on 2017-03-07Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disorders
#52 | 2015-02-19 ✅ Patent 9,221,751 granted on 2015-12-29Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disorders
#53 | 2015-02-05 ✅ Patent 9,586,963 granted on 2017-03-07Derivatives of 6-substituted triazolopyridazines as Rev-Erb agonists
#54 | 2014-11-27 ✅ Patent 9,115,073 granted on 2015-08-251,3-diphenylpropane derivatives, preparations and uses thereof
#55 | 2014-10-16 ✅ Patent 8,895,619 granted on 2014-11-25Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disorders
#56 | 2013-05-23 ✅ Patent 8,765,992 granted on 2014-07-01Preparation of chalcone derivatives
#57 | 2012-10-04 ✅ Patent 8,772,342 granted on 2014-07-08Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disorders
#58 | 2012-05-24 ✅ Patent 8,461,212 granted on 2013-06-11Composition based on substituted 1,3-diphenylprop-2-en-1-one derivatives, preparation and uses thereof
#59 | 2011-08-11 ✅ Patent 8,461,183 granted on 2013-06-11PPAR agonist compounds, preparation and uses
#60 | 2011-08-04 ✅ Patent 8,058,308 granted on 2011-11-15Substituted 1,3-diphenylprop-2-en-1-one derivatives, preparation and uses thereof
#61 | 2011-06-09 ✅ Patent 8,258,182 granted on 2012-09-04Substituted 1,3-diphenylpropane derivatives, preparations and uses thereof
#62 | 2010-11-11 ✅ Patent 8,188,148 granted on 2012-05-29Substituted 1,3-diphenylpropane derivatives, preparations and uses thereof
#63 | 2010-05-13 ✅ Patent 8,106,097 granted on 2012-01-31Composition based on substituted 1,3-diphenylprop-2-en-1-one derivatives, preparation and uses thereof
#64 | 2010-01-07SUBSTITUTED IMIDAZOLONE DERIVATIVES, PREPARATIONS AND USES
#65 | 2009-03-05 ✅ Patent 8,048,900 granted on 2011-11-01Use of 15-lipoxygenase inhibitors for treating obesity
#66 | 2008-08-28Method For the Identification of Compounds Modulating Reverse Transport of Cholesterol
#67 | 2008-05-20 ✅ Patent 7,375,135 granted on 2008-05-20Fatty acid derivatives; preparation and uses thereof
#68 | 2008-03-06 ✅ Patent 7,547,729 granted on 2009-06-161,3-diphenylprop-2-en-1-one derivative compounds, preparation method thereof and uses of same
#69 | 2007-02-08 ✅ Patent 7,566,737 granted on 2009-07-28Combinations of substituted 1,3-diphenylprop-2-en-1-one derivatives with other therapeutically active ingredients
#70 | 2006-06-29 ✅ Patent 7,385,082 granted on 2008-06-10Preparation of 1,3-diphenylprop-2-en-1-one derivatives
#71 | 2006-04-13Substituted compounds derived from N-(benzyl)phenylacetamide, preparation and uses
#72 | 2006-03-30 ✅ Patent 7,253,296 granted on 2007-08-07Acylated aminopropanediols and analogues and therapeutic uses thereof
#73 | 2005-11-24 ✅ Patent 7,547,543 granted on 2009-06-16Method for identifying substances useful for treating inflammation using the response element to the ikbalpha ROR receptor
#74 | 2005-08-11 ✅ Patent 7,943,661 granted on 2011-05-17Substituted 1,3-diphenylprop-2-en-1-one derivatives and preparation and uses thereof
#75 | 2005-08-04 ✅ Patent 7,632,870 granted on 2009-12-15Composition based on substituted 1,3-diphenylprop-2-en-1-one derivatives, preparation and uses thereof
#76 | 2005-07-14Compositions and methods for apo-b48 and apo-b100 assay
#77 | 2005-02-10 ✅ Patent 7,368,286 granted on 2008-05-06Method and device for identifying substances capable of modulating adipocyte differentiation
Also check out GENFIT's (Loos, France) applicant profile with 65 patent applications submitted.
24330 ⎘